News
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...
The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...
2d
GlobalData on MSNNovo Nordisk defeated in Wegovy patent dispute by ViatrisThe Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...
LinkGevity is among a cluster of biotech firms in Cambridge working on potential longevity treatments. They include clock.bio ...
1d
The Print on MSNIndia sees 20k bariatric surgeries a year. But blockbusters Mounjaro, Wegovy are shaking up obesity arenaIndia's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...
Explore more
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...
14hOpinion
MedPage Today on MSNThe Rise in Adolescent Bariatric Surgery Doesn't Mean GLP-1s Have FailedWhen glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
A young woman details her experience with the newly available weight loss medication.
Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...
1d
Stacker on MSNHow to find out if weight loss drugs are covered by your insurance, and what to do if they're notGoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
2d
Verywell Health on MSNWhat Happens to Your Body When You Stop Taking OzempicMany people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results